1. Home
  2. Author
  3. van Exel E

van Exel E

References (2)

Title : Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods - Henstra_2022_Front.Psychiatry_13_953686
Author(s) : Henstra MJ , Feenstra TC , Kok RM , Spaans HP , van Exel E , Dols A , Oudega M , Vergouwen ACM , van der Loo A , Bet PM , Loer SA , Eikelenboom M , Sienaert P , Lambrichts S , Bouckaert F , Bosmans JE , van der Velde N , Beekman ATF , Stek ML , Rhebergen D
Ref : Front Psychiatry , 13 :953686 , 2022
Abstract :
PubMedSearch : Henstra_2022_Front.Psychiatry_13_953686
PubMedID: 35911242

Title : Cognitive Impairment and Electroconvulsive Therapy in Geriatric Depression, What Could be the Role of Rivastigmine? A Case Series - van Schaik_2015_Clin.Pract_5_780
Author(s) : van Schaik AM , Rhebergen D , Henstra MJ , Kadouch DJ , van Exel E , Stek ML
Ref : Clin Pract , 5 :780 , 2015
Abstract :
PubMedSearch : van Schaik_2015_Clin.Pract_5_780
PubMedID: 26664715